Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.41 +0.05 (+3.66%)
As of: Sep 30, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) Operating Income (2020 - 2026)

Updated

Nautilus Biotechnology (NAUT) recorded Operating Income of -$15.76 million in Q2 2026, compared with -$17.1 million a year earlier.

Analysis

Nautilus Biotechnology (NAUT) Operating Income (2020 - 2026) Analysis & Trends

On a TTM basis, Nautilus Biotechnology's Operating Income came in at -$34.83 million as of Jun 30, 2026; for FY2020, it came in at -$576,035.

  • The Q2 2026 figure is the highest quarterly Operating Income since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 2.09 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 1.69 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 1.13 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 971.90 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 1.76 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 1.66 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 1.18 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 513.20 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 663.00 Mn
10 Nautilus Biotechnology 174.30 Mn 174.30 Mn 175,000.00 -15.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.76 Mn
Jun 30, 2025 -17.10 Mn
Mar 31, 2021 -1.78 Mn
Sep 30, 2020 -174,671.00
API Access

Nautilus Biotechnology Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=NAUT&period=max&api_key=YOUR_API_KEY